Compare Abeona Therapeutics Inc (ABEO) vs Global X CleanTech (CTEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Global X CleanTech — how do they compare? Abeona Therapeutics Inc trades at $6.71 (market cap $373.32M), while Global X CleanTech trades at $58. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Global X CleanTech nearer its low. Which is the better fit depends on your goals.
| ABEO | CTEC | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $78.11 |
52-Week Low | $4.17 | $38.45 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
CTEC trades at $62.95, up 2.15% today, but technical indicators show a bearish trend with moving averages signaling caution. The stock faces resistance near $63 with support at $61. Recent news highlights Deutsche Bank maintaining a buy rating ahead of the company's Capital Markets Day, viewing it as a credibility test for growth targets. Financial ratios remain undisclosed in current data.
The outlook hinges on execution of growth targets, with potential upside if management delivers on guidance. Risks include competitive pressures and market volatility. Analyst optimism exists, but investors need confirmation of fundamental improvements during upcoming corporate events to drive sustained price appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →
